Back

prof. dr. J.P. (Jelle) Ruurda

Full Professor

  • Department of Surgical Oncology

prof. dr. J.P. (Jelle) Ruurda

Research Programs

Side Activities

  • Chairman committee on healthcare evaluation FMS

    Member of the board of the Dutch society for gastrointestinal surgery

    Proctor Intuitive Surgical

Research Output (246)

The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer

Gertsen E. C., de Jongh C., Brenkman H. J.F., Mertens A. C., Broeders I. A.M.J., Los M., Boerma D., ten Bokkel Huinink D., van Leeuwen L., Wessels F. J., van Hillegersberg R., Ruurda J. P. jul 2020, In: European Journal of Surgical Oncology. 46 , p. 1247-1253

Metastatic incidence of (PET)CT positive lung hilar and retroperitoneal lymph nodes in esophageal cancer patients

Schurink B., Mazza E., Ruurda J. P., Roeling T. A.P., Bleys R. L.A.W., van Hillegersberg R. 1 jun 2020, In: Surgical Oncology. 33 , p. 170-176 7 p.

3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy

Boekhoff M. R., Defize I. L., Borggreve A. S., Takahashi N., van Lier A. L.H.M.W., Ruurda J. P., van Hillegersberg R., Lagendijk J. J.W., Mook S., Meijer G. J. 1 jun 2020, In: Radiotherapy and Oncology. 147 , p. 1-7 7 p.

Do esophageal cancer survivors work after esophagectomy and do health problems impact their work? A cross-sectional study

Kingma B. F., Rauwerdink P., Brenkman H. J.F., Ruurda J. P., van Hillegersberg R. 1 jun 2020, In: Journal of Cancer Survivorship. 14 , p. 253-260 8 p.

Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer:a propensity-matched analysis

Tagkalos E, Goense L, Hoppe-Lotichius M, Ruurda J P, Babic B, Hadzijusufovic E, Kneist W, van der Sluis P C, Lang H, van Hillegersberg R, Grimminger P P 15 apr 2020, In: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 33 6 p.

Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer

Borggreve Alicia S, Heethuis Sophie E, Boekhoff Mick R, Goense Lucas, van Rossum Peter S N, Brosens Lodewijk A A, van Lier Astrid L H M W, van Hillegersberg Richard, Lagendijk Jan J W, Mook Stella, Ruurda Jelle P, Meijer Gert J 1 apr 2020, In: European Radiology. 30 , p. 1896-1907 12 p.

Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma

Anderegg Martinus C J, Ruurda Jelle P, Gisbertz Suzanne S, Blom Rachel L G M, Sosef Meindert N, Wijnhoven Bas P L, Hulshof Maarten C C M, Bergman Jacques J G H M, van Laarhoven Hanneke W M, van Berge Henegouwen Mark I apr 2020, In: European Journal of Surgical Oncology. 46 , p. 626-631 6 p.

The potential and challenges of patient-derived organoids in guiding the multimodality treatment of upper gastrointestinal malignancies

Busslinger Georg A, Lissendorp Fianne, Franken Ingrid A, van Hillegersberg Richard, Ruurda Jelle P, Clevers Hans, de Maat Michiel F G apr 2020, In: Open Biology. 10 6 p.

Identification of the clinically most relevant postoperative complications after gastrectomy: a population-based cohort study

Gertsen Emma C, Goense Lucas, Brenkman Hylke J F, van Hillegersberg Richard, Ruurda Jelle P, mrt 2020, In: Gastric Cancer. 23 , p. 339-348 10 p.

Vital Signs Monitoring with Wearable Sensors in High-risk Surgical Patients:A Clinical Validation Study

Breteler Martine J M, KleinJan Eline J, Dohmen Daan A J, Leenen Luke P H, van Hillegersberg Richard, Ruurda Jelle P, van Loon Kim, Blokhuis Taco J, Kalkman Cor J mrt 2020, In: Anesthesiology. 132 , p. 424-439 16 p.

All Research Output (246)